CUSIP: 641871108
Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
64,032,004
-
Share change
-
+62,764,848
-
Total reported value
-
$911,821,364
-
Put/Call ratio
-
50%
-
Price per share
-
$14.24
-
Number of holders
-
67
-
Value change
-
+$893,771,296
-
Number of buys
-
60
Quarterly Holders Quick Answers
What is CUSIP 641871108?
CUSIP 641871108 identifies AMAM - AMBRX BIOPHARMA INC - COM in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 641871108:
Institutional Holders of AMBRX BIOPHARMA INC - COM (AMAM) as of Q4 2023
As of 31 Dec 2023,
AMBRX BIOPHARMA INC - COM (AMAM) was held by
67 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
64,032,004 shares.
The largest 10 holders included
Darwin Global Management, Ltd., Cormorant Asset Management, LP, Paradigm Biocapital Advisors LP, D. E. Shaw & Co., Inc., Deep Track Capital, LP, Nextech Invest Ltd., BALYASNY ASSET MANAGEMENT L.P., Logos Global Management LP, VR Adviser, LLC, and CITADEL ADVISORS LLC.
This page lists
67
institutional shareholders reporting positions in this security
for the Q4 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.